NCT05308680View on ClinicalTrials.gov

Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination Among Israeli Health Care Workers

CompletedOBSERVATIONAL

Enrollment

336

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

January 24, 2022

Study Completion Date

March 28, 2022

Conditions

Myocardial InjuryVaccine Adverse ReactionCOVID-19

Interventions

BIOLOGICAL

BNT162b2

Administration of the fourth dose BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19

Trial Locations (1)

Unknown

Shaare zedek MC, Jerusalem

All Listed Sponsors

lead

Shaare Zedek Medical Center

OTHER

NCT05308680 - Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination Among Israeli Health Care Workers | Biotech Hunter | Biotech Hunter